Objective The use of therapeutic hypothermia (TH) for mild hypoxic–ischaemic
encephalopathy (HIE) remains controversial and inconsistent. We analysed trends in TH …

Objective To characterize the implementation of hypothermia for neonatal hypoxic ischemic
encephalopathy (HIE) in a population-based cohort. Study design Using the California …

Objective Hypoxic-ischaemic encephalopathy (HIE) remains a leading cause of neonatal
mortality and neurodisability. We aimed to determine the incidence of HIE and management …

Aim Therapeutic hypothermia is standard of care in term infants with moderate‐to‐severe
hypoxic–ischaemic encephalopathy (HIE). The goal of this survey was to explore the …

Objective Therapeutic hypothermia (TH) for neonatal hypoxic-ischaemic encephalopathy
(HIE), delivered mainly in tertiary cooling centres (CCs), reduces mortality and …

Objectives Therapeutic hypothermia is an effective neuroprotective intervention for infants
with moderate or severe hypoxic-ischemic encephalopathy (HIE). With the introduction of …

Objective To characterize variations in practices and outcomes for neonates with hypoxic-
ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) across Canadian …

BACKGROUND: Birth asphyxia in term neonates remains a serious condition that causes
significant mortality and longterm neurodevelopmental sequelae despite hypothermia …

Importance Therapeutic hypothermia reduces risk of death and disability in infants with
moderate to severe hypoxic ischemic encephalopathy (HIE). Randomized clinical trials of …

Objective To compare therapeutic hypothermia (TH) treatment of term and near-term
neonates with hypoxic-ischemic encephalopathy (HIE) between neonatal units. Study …